Moon Surgical's Maestro System powered by NVIDIA Holoscan paves the way to next-generation laparoscopy, with over 200 patients treated

2024-03-19
PRNewswire
PARIS and SAN FRANCISCO, March 19, 2024 /PRNewswire/ --
Moon Surgical's Maestro, with embarked NVIDIA Holoscan, delivers surgeon autonomy in the first commercial use.
Moon Surgical today announced that over 200 patients have been successfully treated with its Maestro System, powered by NVIDIA Holoscan, which delivers surgeon autonomy in its first commercial use in various surgical interventions.
Continue Reading
"Maestro System powered by NVIDIA Holoscan paves the way to next-generation laparoscopy, with over 200 patients treated" - Kimberly Powell, Vice President of Healthcare at NVIDIA
Post this
The Maestro System is used in laparoscopy, where surgeons operate through small incisions with an internal camera and instruments. The System is powered by NVIDIA Holoscan, a powerful edge computing platform that allows real-time algorithms based on Artificial Intelligence (AI) to be deployed in the operating room for immediate benefits during surgery.
In late 2021, Moon Surgical earned a spot in NVIDIA's Inception Program, designed to accelerate startup growth by providing access to advanced technical resources and pioneering technology. One such technology was the NVIDIA Holoscan, NVIDIA's inaugural platform dedicated to medical technology, which the Moon Surgical team provided input on during development. Moon Surgical has now integrated Holoscan into its commercial Maestro System to enable its first computer vision-based capability, the ScoPilot™.
Maestro's ScoPilot provides autonomy for the surgeon, who must normally rely on other staff to control the laparoscope. This task requires continuous coordination and anticipation. Surgeons can use ScoPilot to control the laparoscope themselves without taking their hands off surgical instruments, which are often engaged with other critical surgical tasks. Over ten surgeons have used the Maestro System and ScoPilot across two hospitals in France.
"Surgeons are astounded by the fluidity and speed that ScoPilot introduces to the operating room," remarked Anne Osdoit, CEO of Moon Surgical and Partner at Sofinnova Partners. "This is the perfect illustration that Maestro is ready for more digital features, enabled by NVIDIA Holoscan, that deliver transformative experiences for the operating room."
"AI is at the top of mind for the next wave of MedTech innovators like Moon Surgical, who seek to deliver innovative solutions to surgeons, nurses, and patients," stated Kimberly Powell, Vice President of Healthcare at NVIDIA. "This proof-of-concept showing an AI application running on NVIDIA Holoscan in real-time during Maestro surgery validates the principle behind our platform."
Moon Surgical, based in Paris, France, and San Francisco, California, is building the OR of the future, one that is digitalized, efficient, and sustainable. The combined power of the transformative Maestro System and the intelligent Maestro OS empowers healthcare teams to make confident decisions and provide better surgical care for their patients. Founded in 2020, Moon Surgical prides itself on staying nimble, prioritizing innovation, and building a culture of inclusivity, creativity, and collaboration among its multi-cultural team members.
Moon Surgical. Inspiring and Innovating the Art of Surgery.
Check us out at www.moonsurgical.com or follow us on LinkedIn.
SOURCE Moon Surgical
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
机构
适应症
-
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。